Arrowhead Pharmaceuticals, Inc. (0HI3.L)

USD 21.69

(-2.58%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 765.55 Million 691.93 Million 710.14 Million 522.5 Million 349.84 Million 111.6 Million
Total Current Assets 110.89 Million 376.39 Million 384.59 Million 322.37 Million 265.24 Million 78.76 Million
Cash And Short Term Investments 110.89 Million 376.39 Million 367.78 Million 315.49 Million 258.7 Million 76.53 Million
Cash and Cash Equivalents 110.89 Million 108 Million 184.43 Million 143.58 Million 221.8 Million 30.13 Million
Short Term Investments 292.73 Million 268.39 Million 183.35 Million 171.9 Million 36.89 Million 46.4 Million
Net Receivables - 1.41 Million 10.25 Million 845.67 Thousand 661.36 Thousand 327.37 Thousand
Inventory - -21.61 Million 4.36 Million 4.25 Million 3.31 Million 1.26 Million
Other Current Assets 7.08 Million 20.2 Million 2.19 Million 1.78 Million 2.56 Million 640.11 Thousand
Total Non-Current Assets 654.66 Million 315.54 Million 325.55 Million 200.13 Million 84.59 Million 32.84 Million
Net PPE 335.55 Million 168.58 Million 66.02 Million 47.01 Million 23.21 Million 13.93 Million
Good Will And Intangible Assets 10.26 Million 11.96 Million 13.66 Million 15.36 Million 17.06 Million 18.76 Million
Good Will - - - - - -
Intangible Assets 10.26 Million 11.96 Million 13.66 Million 15.36 Million 17.06 Million 18.76 Million
Long-Term Investments 292.73 Million 105.87 Million 245.59 Million 137.48 Million 44.17 Million -
Tax Assets -345.82 Million - - - - -
Other Non Current Assets 361.92 Million 29.12 Million 272 Thousand 265.35 Thousand 144.14 Thousand 141.91 Thousand
Other Assets - - - - - -
Total Liabilities 478.39 Million 585.97 Million 301.32 Million 60.72 Million 105.8 Million 16.36 Million
Total Current Liabilities 866 Thousand 74.09 Million 146.53 Million 40.68 Million 97.07 Million 12.36 Million
Account Payables 35.86 Million 2.86 Million 9.45 Million 6.82 Million 7.64 Million 2.8 Million
Tax Payables - - - - - -
Short Term Debt 10.56 Million 2.77 Million 2.25 Million 1.09 Million 11.63 Million 223.82 Thousand
Deferred Revenue 866 Thousand 74.09 Million 111.05 Million 19.29 Million 77.76 Million 600.00
Other Current Liabilities -46.42 Million -5.64 Million 23.77 Million 13.46 Million 16.56 Thousand 9.33 Million
Total Non Current Liabilities 477.52 Million 511.88 Million 154.79 Million 20.04 Million 8.73 Million 4 Million
Long-Term Debt 104.6 Million 78.8 Million 23.29 Million 20.04 Million - 2.1 Million
Deferred Revenue Non Current - 55.95 Million 131.49 Million - 5.03 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 372.91 Million 377.13 Million 131.49 Million - 3.7 Million 1.9 Million
Other Liabilities - - - - - -
Total Equity 287.16 Million 125.77 Million 408.82 Million 461.77 Million 244.03 Million 95.24 Million
Stock Holders Equity 271.34 Million 105.96 Million 408.82 Million 461.77 Million 244.59 Million 95.79 Million
Common Stock 200 Thousand 105.96 Million 197 Thousand 194.74 Thousand 187.87 Thousand 180.87 Thousand
Retained Earnings -1.02 Billion -820.75 Million -644.69 Million -503.84 Million -419.29 Million -487.26 Million
Accumulated other comprehensive income -3.22 Million -136 Thousand -69 Thousand 18.43 Thousand -391.62 Thousand -21.56 Thousand
Common Stock Equity 271.34 Million 105.96 Million 408.82 Million 461.77 Million 244.59 Million 95.79 Million
Capital Lease Obligation 115.17 Million 81.57 Million 25.54 Million 21.13 Million - -
Total Investments 292.73 Million 374.26 Million 428.95 Million 309.39 Million 81.07 Million 46.4 Million
Total Debt 115.17 Million 81.57 Million 25.54 Million 21.13 Million - 2.32 Million
Net Debt 4.28 Million -26.42 Million -158.88 Million -122.44 Million -221.8 Million -27.8 Million

Balance Sheet Charts